GoSpiro— 510(k) K202837

Substantially Equivalent

Monitored Therapeutics, Inc.

FDA 510(k) clearance K202837 for GoSpiro, Substantially Equivalent on 2020-12-04. Applicant: Monitored Therapeutics, Inc..

Clearance details

Applicant: Monitored Therapeutics, Inc.
Product code: Code BZG
Advisory panel: Anesthesiology
Date received: 2020-09-25
Decision date: 2020-12-04
Decision: Substantially Equivalent
Clearance type: Special
Location: Dublin, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.